David Cole to Neoplasm Metastasis
This is a "connection" page, showing publications David Cole has written about Neoplasm Metastasis.
Connection Strength
0.332
-
The molecular detection of micrometastatic breast cancer. Am J Surg. 2003 Oct; 186(4):351-8.
Score: 0.203
-
Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
Score: 0.043
-
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
Score: 0.026
-
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013 Dec; 258(6):879-86.
Score: 0.026
-
Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
Score: 0.014
-
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
Score: 0.010
-
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer. 1999 Nov; 81(6):1002-8.
Score: 0.010